Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma

Explore clinical trials studying Glioblastoma. Study availability and eligibility vary by location and protocol.

1,472 public trials 302 recruiting studies

Glioblastoma trial results

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Henry Ford Hospital Detroit, Michigan, United States
Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +115 more
Locations
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
  • Spital Buelach Bülach, Switzerland
Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Denise Damek Aurora, Colorado, United States
View all 17 locations
Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View all 14 locations
Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Erlangen, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Freiburg im Breisgau, Germany